Bascom Palmer Eye Institute Performs First-in-Florida Surgery Following FDA Approval to Treat Rare Retinal Disease
February 19, 2026
February 19, 2026
MIAMI, Florida, Feb. 19 -- The University of Miami Miller School of Medicine posted the following news:
* * *
Bascom Palmer Eye Institute Performs First-in-Florida Surgery Following FDA Approval to Treat Rare Retinal Disease
*
Summary
* Macular telangiectasia type 2, or MacTel, is a rare eye disease that causes severe central vision loss.
* Bascom Palmer Eye Institute's Dr. Thomas Albini performed the first su . . .
* * *
Bascom Palmer Eye Institute Performs First-in-Florida Surgery Following FDA Approval to Treat Rare Retinal Disease
*
Summary
* Macular telangiectasia type 2, or MacTel, is a rare eye disease that causes severe central vision loss.
* Bascom Palmer Eye Institute's Dr. Thomas Albini performed the first su . . .